Last updated: 2026-09-16 11:04:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Precipio, Inc. (PRPO) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NASDAQ. The stock is currently priced at $27.44, with a market capitalisation of $48.75M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $16.00 to $33.63. This page covers its latest market performance, valuation, price trends and company information.
$48.75M | |
$27.23 | |
$8,448.00 | |
$3.90 | |
$27.23 | |
110.54K | |
116.27K | |
-- | |
$33.63 | |
$16.00 | |
-- | |
-- |
Precipio, Inc. (PRPO) is trading at $27.26 in pre-market trading as of 2026-09-15 23:31:00, up 0.09% ($0.02) from the previous close of $27.23
Pre-market trading shows how investors are pricing PRPO before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, Precipio, Inc. (PRPO) moved from $27.40 to $27.44, representing a gain of 0.13% ($0.04).
The stock traded between $24.48 and $28.00 during the period. The latest price is near the upper end of the 7-day range, indicating range-bound.
The average daily volume was 150.07 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 64.9%
PRPO is currently trading at $27.44, placing it 64.9% of the way from its 52-week low of $16.00 to its 52-week high of $33.63. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
| Industry | LABORATORY ANALYTICAL INSTRUMENTS |
| Employees | 71 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Precipio, Inc. (PRPO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.